Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2

Journal of Endocrinology

Volumn 195, Issue 1, 2007, Pages 89-94

  Wu, Quan ^a   Zhou, Ying ^a   Chen, Linfeng ^a,b   Shi, Jiandang ^a   Wang, Chun Yu ^a   Miao, Lin ^a   Klocker, Helmut ^c   Park, Irwin ^d   Lee, Chung ^d   Zhang, Ju ^a  

^a NANKAI UNIVERSITY   (China)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CYCLOOXYGENASE 2; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIUM CELL; HUMAN; HUMAN CELL; MALE; MOLECULAR MECHANICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; STROMA CELL;

AROMATASE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DINOPROSTONE; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; MALE; PARACRINE COMMUNICATION; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS;

EID: 35848969817     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/JOE-06-0181     Document Type: Article

References (18)

1. Bulun SE, Imir G, Utsunomiya H, Thung S, Gurates B, Tamura M & Lin Z 2005 Aromatase in endometriosis and uterine leiomyomata. Journal of Steroid Biochemistry and Molecular Biology 95 57-62.
2. Fisher CR, Graves KH, Parlow AF & Simpson ER 1998 Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. PNAS 95 6965-6970.
3. Hiramatsu M, Maehara I, Ozaki M, Harada N, Orikasa S & Sasano H 1997 Aromatase in hyperplasia and carcinoma of the human prostate. Prostate 31 118-124.
4. Isidori AM, Strollo F, More M, Caprio M, Aversa A, Moretti C, Frajese G, Riondino G & Fabbri A 2000 Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. Journal of Clinical Endocrinology and Metabolism 85 1954-1962.
5. Kaburagi Y, Marino MB, Kirdani RY, Greco JP, Karr JP & Sandberg AA 1987 The possibility of aromatization of androgen in human prostate. Journal of Steroid Biochemistry 26 739-742.
6. Krieg M, Nass R & Tunn S 1993 ETect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. Journal of Clinical Endocrinology and Metabolism 77 375-381.
7. Matzkin H & Soloway MS 1992 Immunohistochemical evidence of the existence and localization of aromatase in human prostatic tissues. Prostate 21 309-314.
8. Negri-Cesi P, Colciago A, Poletti A & Motta M 1999 5alpha-reductase isozymes and aromatase are diferentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3. Prostate 41 224-232.
9. Rubens R, Dhont M & Vermeulen A 1974 Further studies on Leydig cell function in old age. Journal of Clinical Endocrinology and Metabolism 39 40-45.
10. Sebastian S & Bulun SE 2001 A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project. Journal of Clinical Endocrinology and Metabolism 86 4600-4602.
11. Seppelt U 1978 Correlation among prostate stroma, plasma estrogen levels, and urinary estrogen excretion in patients with benign prostatic hypertrophy. Journal of Clinical Endocrinology and Metabolism 47 1230-1235.
12. Shibata Y, Ito K, Suzuki K, Nakano K, Fukabori Y, Suzuki R, Kawabe Y, Honna S & Yamanaka H 2000 Changes in the endocrine environment of the human prostate transition zone with aging: simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition. Prostate 42 45-55.
13. Simpson ER, Michael MD, Agarwal VR, Hinshelwood MM, Bulun SE & Zhao Y 1997 Cytochromes P450 11: expression of the CYP19 (aromatase) gene: an unusual case of alternative promoter usage. FASEB Journal 11 29-36.
14. Stone NN, Laudone V-P, Fair WR & Fishman J 1987 Aromatization of androstenedione to estrogen by benign prostatic hyperplasia, prostate cancer and expressed prostatic secretions. Urological Research 15 165-167.
15. Tsugaya M, Harada N, Tozawa K, Yamada Y, Hayashi Y Tanaka S & Maruyama K 1996 Aromatase mRNA levels in benign prostatic hyperplasia and prostate cancer. International Journal of Urology 3 292-296.
16. Watanabe M, Noda M & Nakajin S 2006 Effect of epidermal growth factor and prostaglandin on the expression of aromatase (CYP19) in human adrenocortical carcinoma cell line NCI-H295R cells. Journal of Endocrinology 188 59-68.
17. Zhang J, Hess MW, Thurnher M, Hobisch A, Radmayr C, Cronauer MV, Hittmair A, Culig Z, Bartsch G & Klocker H 1997 Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markers. Prostate 30 117-129.
18. Zhao Y, Agarwal VR, Mendelson CR & Simpson ER 1996 Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137 5739-5742.